Content about Osteoporosis

April 18, 2013

A new study by Kaiser Permanente finds that a large percentage of women with osteoporosis fail to pick up new prescriptions for the condition.

PASADENA, Calif. — A new study by Kaiser Permanente finds that a large percentage of women with osteoporosis fail to pick up new prescriptions for the condition.

April 4, 2013

Dr. Reddy's Labs has launched zoledronic acid injection in the 5 mg-per-100-mL strength, the Indian generic drug maker Thursday.

HYDERABAD, India — Dr. Reddy's Labs has launched zoledronic acid injection in the 5 mg-per-100-mL strength, the Indian generic drug maker Thursday.

The drug, launched following its approval by the Food and Drug Administration, is a generic version of Novartis' Reclast and is used to treat osteoporosis. Reclast had sales of $355 million during the 12-month period that ended in February, according to IMS Health.

March 6, 2013

The Nutritional Magnesium Association noted magnesium is an essential nutrient that helps absorb necessary nutritional supplements like vitamin D or calcium in response to a recent U.S. Preventive Services Task Force report that suggested supplementing with these ingredients may not help prevent bone fractures in postmenopausal women, while also increasing the risk of kidney stones.

LOS ANGELES — The Nutritional Magnesium Association on Wednesday noted magnesium is an essential nutrient that helps absorb necessary nutritional supplements like vitamin D or calcium in response to a recent U.S. Preventive Services Task Force report that suggested supplementing with these ingredients may not help prevent bone fractures in postmenopausal women, while also increasing the risk of kidney stones. 

February 26, 2013

The U.S. Preventive Services Task Force on Monday issued a trio of controversial recommendations regarding supplementing with vitamin D and calcium.

WASHINGTON — The U.S. Preventive Services Task Force on Monday issued a trio of controversial recommendations regarding supplementing with vitamin D and calcium. Specifically, the Task Force determined that the current evidence was insufficient to support vitamin D and calcium supplementation for the primary prevention of fractures in premenopausal women, in men or in postmenopausal women and recommended against daily supplementation of vitamin D or calcium toward that end. 

February 7, 2013

CVS Caremark has announced the extension of its Pharmacy Advisor program to cover an additional five chronic conditions, including asthma, breast cancer, chronic obstructive pulmonary disease, depression and osteoporosis.

WOONSOCKET, R.I. — CVS Caremark has announced the extension of its Pharmacy Advisor program to cover an additional five chronic conditions, including asthma, breast cancer, chronic obstructive pulmonary disease, depression and osteoporosis.

February 5, 2013

A JAMA report released suggested a high intake of supplemental calcium is associated with an increased risk of cardiovascular disease death in men was criticized by several dietary supplement agencies for being inconclusive.

CHICAGO — A JAMA report released Monday afternoon that suggested a high intake of supplemental calcium is associated with an increased risk of cardiovascular disease death in men was criticized by several dietary supplement agencies for being inconclusive. According to the Council for Responsible Nutrition's most recent survey of U.S. adults, 17% indicated they take a calcium supplement.

November 28, 2012

The Council for Responsible Nutrition on Wednesday announced it is partnering with the National Osteoporosis Foundation in hosting a free webinar for pharmacists and nurse practitioners around updated recommendations and research of calcium and vitamin D.

WASHINGTON — The Council for Responsible Nutrition on Wednesday announced it is partnering with the National Osteoporosis Foundation in hosting a free webinar for pharmacists and nurse practitioners around updated recommendations and research of calcium and vitamin D. 

October 11, 2012

Mission Pharmacal has launched what it called an alternative to pill therapy for osteoporosis.

SAN ANTONIO — Mission Pharmacal has launched what it called an alternative to pill therapy for osteoporosis.

The drug maker announced Thursday the availability of Binosto (alendronate sodium) effervescent tablets for buffered oral solution in pharmacies. The drug is used to treat osteoporosis in postmenopausal women and increase bone mass in men with the condition.

September 21, 2012

The Food and Drug Administration has approved a new usage for an Amgen drug, the drug maker said.

THOUSAND OAKS, Calif. — The Food and Drug Administration has approved a new usage for an Amgen drug, the drug maker said.

The biotech manufacturer announced the FDA approval of Prolia (denosumab) to increase bone mass in men with osteoporosis who are at high risk for fracture. The drug already was approved for osteoporosis in postmenopausal women.

September 10, 2012

Some of the most commonly cited health problems affecting the elderly are hypertension, stroke and osteoporosis, but a new study highlights what researchers call an even bigger problem.

MINNETONKA, Minn. — Some of the most commonly cited health problems affecting the elderly are hypertension, stroke and osteoporosis, but a new study highlights what researchers call an even bigger problem.

Americans ages 65 years and older said that hearing impairment affects their quality of life physically and mentally more than high blood pressure, stroke, osteoporosis, sciatica and cancer, according to the study, released Thursday by AARP Services and UnitedHealthcare.

August 7, 2012

A biotech drug made by Eli Lilly for osteoporosis appeared no more or less effective than a pharmaceutical drug available as a generic in treating women with related bone fractures, but was more effective in some other measures, according to results of a late-stage clinical trial released Tuesday.

INDIANAPOLIS — A biotech drug made by Eli Lilly for osteoporosis appeared no more or less effective than a pharmaceutical drug available as a generic in treating women with related bone fractures, but was more effective in some other measures, according to results of a late-stage clinical trial released Tuesday.

June 15, 2012

The Council for Responsible Nutrition on Thursday issued a response to a U.S. Preventive Services Task Force draft recommendation around the ineffectiveness of vitamin D and calcium to prevent cancer or fractures.

WASHINGTON — The Council for Responsible Nutrition on Thursday issued a response to a Preventive Services Task Force draft recommendation around the ineffectiveness of vitamin D and calcium to prevent cancer or fractures. The draft guidance also suggested vitamin D and calcium could equate to a greater risk of kidney stones in older women.

June 15, 2012

A study recently published in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism suggests that vitamin D — when taken with calcium — can reduce the rate of mortality in seniors, thereby providing a possible means of increasing life expectancy, the society reported Friday.

CHEVY CHASE, Md. — A study recently published in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism suggests that vitamin D — when taken with calcium — can reduce the rate of mortality in seniors, thereby providing a possible means of increasing life expectancy, the society reported Friday.

April 17, 2012

A U.S. drug maker has made a deal with a Swiss company to manufacture and sell a new osteoporosis treatment in North America.

SAN ANTONIO — A U.S. drug maker has made a deal with a Swiss company to manufacture and sell a new osteoporosis treatment in North America.

Mission Pharmacal announced Tuesday a patent and technology licensing agreement with Freienbach, Switzerland-based EffRx Pharmaceuticals for Binosto (alendronate sodium) effervescent tablets in the United States and Canada. Financial terms were not disclosed.

March 21, 2012

The Food and Drug Administration has approved Watson's generic version of a drug used to prevent and treat osteoporosis in post-menopausal women, the company said.

PARSIPPANY, N.J. — The Food and Drug Administration has approved Watson's generic version of a drug used to prevent and treat osteoporosis in post-menopausal women, the company said.

Watson announced the FDA's approval of ibandronate tablets in the 150-mg strength, a generic version of Genentech's Boniva. Watson plans to launch its version in second quarter 2012.

March 19, 2012

The Food and Drug Administration has approved the first generic version of a drug for treating and preventing osteoporosis in women after menopause, the agency said Monday.

SILVER SPRING, Md. — The Food and Drug Administration has approved the first generic version of a drug for treating and preventing osteoporosis in women after menopause, the agency said Monday.

The FDA announced the approval of ibandronate tablets in the 150-mg strength made by Apotex, Orchid Healthcare and Mylan Pharmaceuticals. Genentech makes the branded version of the drug.

March 15, 2012

The Food and Drug Administration approved an effervescent tablet for treating osteoporosis.

FREIENBACH, Switzerland — The Food and Drug Administration approved an effervescent tablet for treating osteoporosis.

EffRx Pharmaceuticals announced the FDA approval of Binosto (alendronate sodium), a strawberry-flavored tablet designed to dissolve in water that the company called the first treatment of its kind. The drug is designed to treat osteoporosis in menopausal women and increase bone mass in men with osteoporosis. EffRx expects to launch Binosto in third quarter 2012.

February 8, 2012

CVS/pharmacy announced on Wednesday the launch of Project Health (Proyecto Salud in Spanish), a wellness program delivering more than $21 million worth of free health screenings to multicultural communities.

WOONSOCKET, R.I. — CVS/pharmacy announced on Wednesday the launch of Project Health (Proyecto Salud in Spanish), a wellness program delivering more than $21 million worth of free health screenings to multicultural communities.

September 19, 2011

The Food and Drug Administration has approved two new uses for a drug made by Amgen, the drug maker said Monday.

THOUSAND OAKS, Calif. — The Food and Drug Administration has approved two new uses for a drug made by Amgen, the drug maker said Monday.

Amgen announced the approval of the biotech drug Prolia (denosumab) for increasing bone mass in men and women who are at risk of fractures due to hormone ablation treatments they are receiving for prostate and breast cancer, respectively.

September 15, 2011

Without magnesium, calcium supplements increase risk of heart attacks, according to a meta-analysis recently conducted by Carolyn Dean, medical director of the Nutritional Magnesium Association.

ORANGE, Calif. — Without magnesium, calcium supplements increase risk of heart attacks, according to a meta-analysis recently conducted by Carolyn Dean, medical director of the Nutritional Magnesium Association.

"If we consume too much calcium without sufficient magnesium, the excess calcium is not utilized correctly and may actually become toxic, causing painful conditions, such as some forms of arthritis, kidney stones, osteoporosis and calcification of the arteries leading to heart attack and cardiovascular disease," Dean said.

August 25, 2011

Amgen has launched an educational campaign that targets women with postmenopausal osteoporosis at increased risk for fractures.

THOUSAND OAKS, Calif. — Amgen has launched an educational campaign that targets women with postmenopausal osteoporosis at increased risk for fractures.

The drug maker said that to promote its Act 2 Reduce Fractures campaign, which is supported by American Bone Health, the Global Healthy Living Foundation and the Older Women's League, the company has tapped award-winning actress Blythe Danner, who was diagnosed with the disease, to encourage women to learn of the risk factors and ways to improve their condition.

August 10, 2011

Soy isoflavone tablets do not appear to be associated with a reduction in bone loss or menopausal symptoms in women within the first five years of menopause, according to a report in the Aug. 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

MIAMI — Soy isoflavone tablets do not appear to be associated with a reduction in bone loss or menopausal symptoms in women within the first five years of menopause, according to a report in the Aug. 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

June 1, 2011

Overweight or obese women who have less-than-optimal levels of vitamin D and lose more than 15% of their body weight experience significant increases in circulating levels of this fat-soluble nutrient, according to a study released last week by researchers at Fred Hutchinson Cancer Research Center.

SEATTLE — Overweight or obese women who have less-than-optimal levels of vitamin D and lose more than 15% of their body weight experience significant increases in circulating levels of this fat-soluble nutrient, according to a study released last week by researchers at Fred Hutchinson Cancer Research Center.

May 13, 2011

More than 800 drugs are in development for diseases that affect women, according to a pharmaceutical industry lobbying group.

WASHINGTON — More than 800 drugs are in development for diseases that affect women, according to a pharmaceutical industry lobbying group.

May 12, 2011

Japan-based Takeda Pharmaceutical may acquire Switzerland’s Nycomed for $12 billion, according to published reports.

NEW YORK — Japan-based Takeda Pharmaceutical may acquire Switzerland’s Nycomed for $12 billion, according to published reports.

Reuters reported Thursday that Takeda was in talks to buy Nycomed in order to expand its presence in the European market. Most of Takeda’s business is in Asia and the United States.

Nycomed makes treatments for such diseases as chronic obstructive pulmonary disease, chronic pain, osteoporosis and others.